Pityriasis Folliculorum: Response to Topical Ivermectin
Darji, K.; Burkemper, N.M.
Journal of Drugs in Dermatology Jdd 16(12): 1290-1292
2017
ISSN/ISBN: 1545-9616 PMID: 29240866 Document Number: 17875
Pityriasis folliculorum has been described as a dry type of rosacea with extensive proliferation of Demodex folliculorum in pilosebaceous follicles of the skin. This skin condition is frequently difficult to manage, with various treatment options showing mixed efficacy. Oral ivermectin, a macrocyclic lactone parasiticide with anti-inflammatory and anti-parasitic effects, is one of the leading treatment modalities for demodicosis. Topical ivermectin has recently been FDA approved as therapy for rosacea. We present the case of a woman with pityriasis folliculorum who showed significant improvement from using topical ivermectin with no adverse events related to treatment.
Document emailed within 1 workday
